Project cooperationUpdated on 17 December 2025
Partnership Oppportunities for 2026-01-DISEASE-03:
Founder, CEO at Galata Innovation
Istanbul, Türkiye
About
We are currently assembling a high-impact consortium for the HORIZON-HLTH-2026-01-DISEASE-03 call, focusing on the prevention, diagnosis, and management of post-infection long-term conditions. We are specifically seeking clinical partners interested in leading or contributing to multi-center clinical studies.
Similar opportunities
Project cooperation
Effect of Long Term Exposure to toxins/environmental factors in Cell Models
- Partner seeks Consortium/Coordinator
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
A ArunJunai
Managing Director at EU-Support
Roermond, Netherlands
Project cooperation
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
Charlotte Rasser
Senior Strategy & Scientific Affairs Director at Sysnav
Vernon, France
Project cooperation
Monash University Health Research Capabilities
Susan Feitoza
Director Strategy and Engagement at Monash University
Prato, Italy